SU2C Announcements

Stand Up To Cancer (SU2C) is an unprecedented collaboration uniting the major television networks, entertainment industry executives and celebrities and prominent leaders in cancer research and patient advocacy in a major new initiative to move groundbreaking cancer research out of the lab and into the clinic. SU2C is committed to:

• identifying the most promising opportunities and leveraging its fiscal and management resources to achieve a paradigm shift in clinical cancer research;
• high-quality science in its funding activities and believes that this can be accomplished within the framework of a truly innovative approach to support SU2C-funded research; and
• accountability and transparency. Dream Teams will be required to periodically report on their progress which will be available here.

Stand Up To Cancer Innovative Research Grants Recipients Announced, December 7, 2009
Stand Up To Cancer (SU2C) is awarding $9.68 million to support high-risk/high-reward cancer research conducted by 13 young scientists. Read more.

Stand Up To Cancer Letter from AACR President Tyler Jacks, Ph.D. and AACR CEO Margaret Foti, Ph.D., M.D. (h.c.), May 27, 2009
We are writing this letter toward the end of a whirlwind media announcement that revealed to the world the Stand Up To Cancer (SU2C) Dream Teams that were selected by our stellar Scientific Advisory Committee. Read more.

Stand Up To Cancer (SU2C), the charitable initiative supporting groundbreaking research aimed at getting new cancer treatments to patients in an accelerated timeframe, has reached a significant milestone, awarding the first round of three-year grants — that total $73.6 million — to five multi-disciplinary, multi-institutional research Dream Teams. Read more.

SU2C Innovative Research Grants
The SU2C Innovative Research Grants are a new effort to support the next generation of extraordinary leaders in their quest to conquer cancer. These grants will provide substantial funding to early-career scientists whose novel, high-risk, high-reward cancer research proposals have significant potential for translational application, and hold great promise for advancing SU2C's overarching goal of improving and saving the lives of patients. 

A Progress Report on Stand Up To Cancer, November 2008
As you know, Stand Up To Cancer (SU2C) kicked off on September 5 with a star-studded televised fundraising event that aired simultaneously on all three major U.S. television networks and, indeed, all over the world. The results were amazing: to date, more than $100 million has been raised for cutting-edge translational cancer research programs that hold great promise to improve the quality of patient care and save lives. Read more. (Adobe Acrobat Reader required.)

Stand Up To Cancer: AACR Issues a Call for Ideas to the Cancer Research Community, July 15, 2008
As the scientific partner to Stand Up To Cancer (SU2C), an unprecedented collaboration uniting the major television networks, entertainment industry executives, celebrities and prominent leaders in cancer research and patient advocacy, the American Association for Cancer Research (AACR) issues to the cancer community a call for ideas for translational cancer research projects that hold the most promise for rapid translation into clinical realities. Read more.

ABC, CBS, NBC Announce Historic Collaboration to "Stand Up To Cancer," May 27, 2008
Stand Up To Cancer (www.standup2cancer.org), a new initiative to raise philanthropic dollars for accelerating ground-breaking research, launches today through an unprecedented collaboration uniting the major television networks, entertainment industry executives, celebrities and prominent leaders in cancer research and patient advocacy.  Read more.